Life sciences-focused venture firm Kurma Partners has secured Pasteur Institute for a third fund dedicated to early and incubation-stage therapeutics companies.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

San Raffaele-Telethon gene therapy spinout Genespire has picked up series A funding from Sofinnova Partners to target inherited metabolic diseases and primary immunodeficiencies.

Woodford has faced challenges in selling its shareholdings in spinouts including Oxford Nanopore and Immunocore, but has now lined up Acacia as a potential buyer.

Robocath, which is developing robotic-assisted technology for cardiovascular diseases, has collected capital from investors including TUS-Holdings.

BGU-founded identity verification technology provider Secret Double Octopus has added $15m to its coffers, three years after closing its series A round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NEA has led a series B1 round for the smart contact lens developer, whose existing shareholders include Stanford-StartX.

UT Southwestern has formed central nervous system diseases treatment developer Taysha Gene Therapies with executives who previously worked for OSU's Avexis.

UC-backed Congruent Ventures returned to back EV charger hire service Amply Power four months after contributing to a $3.8m seed round.